Controlled release hydrocodone formulations
First Claim
1. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising an amount of a hydrocodone bitartrate salt equivalent to from about 5 mg to about 60 mg of hydrocodone,the dosage form providinga ratio of a plasma concentration of hydrocodone at the end of a dosing interval to a maximum plasma concentration of hydrocodone during the dosing interval of about 0.55 to about 1, and an effective pain relief over a period of time of about 12 hours or longer after administration to a human patient or a population of patients,an in-vitro release of hydrocodone when measured by the USP Basket method at 100 rpm in 700 ml aqueous buffer at a pH of 1.2 at 37°
- C. of from 10% to about 45% by weight hydrocodone released at 1 hour,the dosage form is a capsule comprisinga first portion of said amount of the hydrocodone bitartrate salt in an immediate release form andthe remaining portion of said amount of the hydrocodone bitartrate salt and a controlled release material in an extended release form, whereinsaid hydrocodone bitartrate salt is the only active agent in the dosage form.
0 Assignments
0 Petitions
Accused Products
Abstract
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
-
Citations
28 Claims
-
1. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising an amount of a hydrocodone bitartrate salt equivalent to from about 5 mg to about 60 mg of hydrocodone,
the dosage form providing a ratio of a plasma concentration of hydrocodone at the end of a dosing interval to a maximum plasma concentration of hydrocodone during the dosing interval of about 0.55 to about 1, and an effective pain relief over a period of time of about 12 hours or longer after administration to a human patient or a population of patients, an in-vitro release of hydrocodone when measured by the USP Basket method at 100 rpm in 700 ml aqueous buffer at a pH of 1.2 at 37° - C. of from 10% to about 45% by weight hydrocodone released at 1 hour,
the dosage form is a capsule comprising a first portion of said amount of the hydrocodone bitartrate salt in an immediate release form and the remaining portion of said amount of the hydrocodone bitartrate salt and a controlled release material in an extended release form, wherein said hydrocodone bitartrate salt is the only active agent in the dosage form. - View Dependent Claims (2, 3, 4)
- C. of from 10% to about 45% by weight hydrocodone released at 1 hour,
-
5. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising an amount of a hydrocodone bitartrate salt equivalent to from about 5 mg to about 60 mg of hydrocodone and a controlled release material,
the controlled release material included in an effective amount such that the dosage form provides an in-vitro release of hydrocodone when measured by the USP Basket method at 100 rpm in 700 ml aqueous buffer at a pH of 1.2 at 37° - C. of from 10% to about 45% by weight hydrocodone released at 1 hour,
a W50 of hydrocodone of between 4 and 22 hours, a Tmax of hydrocodone of from about 4 to about 10 hours and a plasma concentration of hydrocodone within a therapeutic range but below toxic concentrations over a period of time of about 12 hours or longer after administration to a human patient or a population of patients, the dosage form is a capsule comprising a first portion of said amount of the hydrocodone bitartrate salt in an immediate release form and the remaining portion of said amount of the hydrocodone bitartrate salt and the controlled release material in an extended release form, wherein said hydrocodone bitartrate salt is the only active agent in the dosage form. - View Dependent Claims (6, 7, 8, 9, 10)
- C. of from 10% to about 45% by weight hydrocodone released at 1 hour,
-
11. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising an amount of a hydrocodone bitartrate salt equivalent to from about 5 mg to about 60 mg of hydrocodone and a controlled release material,
the controlled release material included in an effective amount such that the dosage form provides an in-vitro release of hydrocodone when measured by the USP Basket method at 100 rpm in 700 ml aqueous buffer at a pH of 1.2 at 37° - C. of from 10% to about 45% by weight hydrocodone released at 1 hour, and
a Tmax of hydrocodone of from about 4 to about 10 hours and a plasma concentration of hydrocodone within a therapeutic range but below toxic concentrations over a period of time of about 12 hours or longer after administration to a human patient or a population of patients, the dosage form is a capsule comprising a first portion of said amount of the hydrocodone bitartrate salt in an immediate release form and the remaining portion of said amount of the hydrocodone bitartrate salt and the controlled release material in an extended release form, wherein said hydrocodone bitartrate salt is the only active agent in the dosage form. - View Dependent Claims (12, 13, 14, 15, 16, 17, 28)
- C. of from 10% to about 45% by weight hydrocodone released at 1 hour, and
-
18. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising an amount of a hydrocodone bitartrate salt equivalent to from about 5 mg to about 60 mg of hydrocodone and a controlled release material,
the controlled release material included in an effective amount such that the dosage form provides an in-vitro release of hydrocodone when measured by the USP Basket method at 100 rpm in 700 ml aqueous buffer at a pH of 1.2 at 37° - C. of from 10% to about 45% by weight hydrocodone released at 1 hour,
the dosage form is a capsule comprising a first portion of said amount of the hydrocodone bitartrate salt in an immediate release form and the remaining portion of said amount of the hydrocodone bitartrate salt and a controlled release material in an extended release form, wherein said hydrocodone bitartrate salt is the only active agent in the dosage form. - View Dependent Claims (19, 20, 21, 22, 23, 24, 25, 26, 27)
- C. of from 10% to about 45% by weight hydrocodone released at 1 hour,
Specification